èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ãã Phathom Pharmaceuticals, Inc. ã¯ãèè
žçŸæ£ã®æ²»çè¬ã®éçºãšåååã«æ³šåããŠããŸããå瀟ã¯ç±³åœã欧å·ãã«ããã§ãèé
žåæ³ãé»å®³ããã«ãªãŠã ç«¶åæ§é
žé®æè¬ (P-CAB) ã§ãããããã©ã¶ã³ã®æš©å©ãä¿æããŠããŸããå瀟ã¯ãŸããã³ããæ§èé£ééæµçã®æ²»çè¬ãšããŠããŸãããªã³ãã¯ã¿ãŒ ãããªææçã®æ²»çè¬ãšããŠæçç©è³ªãšã®äœµçšè¬ãšããŠã第 III çžèšåºè©Šéšäžã®ãããã©ã¶ã³ãéçºããŠããŸããå瀟㯠2018 幎ã«èšç«ããããã¥ãŒãžã£ãŒãžãŒå·ãããŒã©ã ããŒã¯ã«æ¬ç€Ÿã眮ããŠããŸãã